Craig Bijou
Stock Analyst at B of A Securities
(3.85)
# 588
Out of 4,851 analysts
62
Total ratings
64.71%
Success rate
62.12%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Maintains: Buy | $104 → $84 | $59.99 | +40.04% | 4 | Apr 25, 2025 | |
| RXST RxSight | Maintains: Buy | $60 → $36 | $15.81 | +127.70% | 1 | Mar 21, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $121.44 | +15.28% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $11.50 | +47.83% | 3 | Feb 20, 2025 | |
| GMED Globus Medical | Upgrades: Neutral | $80 → $97 | $59.70 | +62.48% | 4 | Jan 9, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $13.04 | +38.04% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $119.85 | +20.98% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $94.59 | +8.89% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $69.66 | +22.02% | 1 | Sep 11, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $71.16 | +20.85% | 2 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $66.91 | +41.98% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $18.89 | +90.58% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $7.26 | +519.83% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $4.41 | +2,621.09% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $5.18 | +479.15% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $10.21 | +27.33% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $11.03 | +280.78% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $551.85 | -58.32% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $381.01 | -39.63% | 4 | Jul 26, 2019 |
PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104 → $84
Current: $59.99
Upside: +40.04%
RxSight
Mar 21, 2025
Maintains: Buy
Price Target: $60 → $36
Current: $15.81
Upside: +127.70%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $121.44
Upside: +15.28%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $11.50
Upside: +47.83%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80 → $97
Current: $59.70
Upside: +62.48%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $13.04
Upside: +38.04%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $119.85
Upside: +20.98%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $94.59
Upside: +8.89%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $69.66
Upside: +22.02%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $71.16
Upside: +20.85%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $66.91
Upside: +41.98%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $18.89
Upside: +90.58%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $7.26
Upside: +519.83%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $4.41
Upside: +2,621.09%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $5.18
Upside: +479.15%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $10.21
Upside: +27.33%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $11.03
Upside: +280.78%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $551.85
Upside: -58.32%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $381.01
Upside: -39.63%